OncoSil Medical (ASX:OSL) Operating Cash Flow per Share : A$-0.01 (TTM As of Dec. 2024)

View and export this data going back to 2005. Start your Free Trial

What is OncoSil Medical Operating Cash Flow per Share?

OncoSil Medical's operating cash flow per share for the six months ended in Dec. 2024 was A$-0.00. OncoSil Medical's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2024 was A$-0.01.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 14.50% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 2.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for OncoSil Medical's Operating Cash Flow per Share or its related term are showing as below:

ASX:OSL' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -196.2 Med: -12.6 Max: 51.3
Current: 14.5

During the past 13 years, OncoSil Medical's highest 3-Year average Operating Cash Flow per Share Growth Rate was 51.30% per year. The lowest was -196.20% per year. And the median was -12.60% per year.

ASX:OSL's 3-Year OCF Growth Rate is ranked better than
58.93% of 694 companies
in the Medical Devices & Instruments industry
Industry Median: 7.5 vs ASX:OSL: 14.50

OncoSil Medical Operating Cash Flow per Share Historical Data

The historical data trend for OncoSil Medical's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OncoSil Medical Operating Cash Flow per Share Chart

OncoSil Medical Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Operating Cash Flow per Share

Get a 7-Day Free Trial

-0.01

OncoSil Medical Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Operating Cash Flow per Share	Get a 7-Day Free Trial															-	-0.01	-	-	-

Competitive Comparison of OncoSil Medical's Operating Cash Flow per Share

For the Medical Devices subindustry, OncoSil Medical's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OncoSil Medical's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, OncoSil Medical's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where OncoSil Medical's Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

OncoSil Medical Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

OncoSil Medical's Operating Cash Flow per Share for the fiscal year that ended in Jun. 2024 is calculated as

Operating Cash Flow per Share (A: Jun. 2024 )	=	Cash Flow from Operations (A: Jun. 2024 )	/	Shares Outstanding (Diluted Average) (A: Jun. 2024 )
	=	-11.127	/	2219.392
	=	-0.01

OncoSil Medical's Operating Cash Flow per Share for the quarter that ended in Jun. 2024 is calculated as

Operating Cash Flow per Share (Q: Dec. 2024 )	=	Cash Flow from Operations (Q: Dec. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Dec. 2024 )
	=	-6.115	/	3975.192
	=	-0.00

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-0.01

OncoSil Medical Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of OncoSil Medical's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

OncoSil Medical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » OncoSil Medical Ltd (ASX:OSL) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

7 Eden Park Drive, Level 5, Macquarie Park, Sydney, NSW, AUS, 2113

Website

https://www.oncosil.com

OncoSil Medical Ltd is a medical device company. It is engaged in the development and commercialization of its product candidate, the OncoSil localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma. It operates in one segment. the device development for new medical treatments. Geographically, the company derives its maximum revenue from Europe and the rest from Australia and New Zealand.

OncoSil Medical Headlines

No Headlines